ImageneBio IMA
NASDAQ IMA
$4.95 -0.06 (-1.20%)
As of: Sep 10, 2026 · 3:59 PM EDT

ImageneBio (IMA) Other Working Capital Changes (2020 - 2025)

ImageneBio's (IMA) quarterly Other Working Capital Changes came in at -$2.6 million in Q3 2025, down 302.0% year-over-year from $1.3 million in Q3 2024, and down 159.64% quarter-over-quarter from $4.4 million in Q2 2025.

Analysis

ImageneBio (IMA) Other Working Capital Changes (2020 - 2025) Analysis & Trends

ImageneBio has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$2.6 million for Q3 2025.

  • In Q3 2025, Other Working Capital Changes fell 302.0% year-over-year to -$2.6 million; the TTM figure through Sep 2025 stood at $700000.0 (up 163.81% YoY), while the FY2024 annual figure was -$3.2 million, down 54.14% from the prior year.
  • Other Working Capital Changes came in at -$2.6 million for Q3 2025 at ImageneBio, down from $4.4 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of -$381000.0 in Q2 2022 to a low of -$20.2 million in Q4 2021.
  • Average Other Working Capital Changes over 4 years is -$4.3 million, with a median of -$3.5 million recorded in 2021.
  • The largest YoY upside for Other Working Capital Changes was 919.47% in 2021 against a maximum downside of 3886.36% in 2021.
  • Over 5 years, Other Working Capital Changes stood at -$1.7 million in 2021, then surged by 66.75% to -$554000.0 in 2022, then slumped by 36.1% to -$754000.0 in 2023, then sank by 281.17% to -$2.9 million in 2024, then grew by 8.42% to -$2.6 million in 2025.
  • Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.6 million in Q3 2025, $4.4 million in Q2 2025, and $1.8 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 ImageneBio 42.89 Mn -92.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -650,000.00
Mar 31, 2025 -650,000.00
Dec 31, 2023 -659,000.00
Dec 31, 2023 -659,000.00
Sep 30, 2023 -1.19 Mn
Sep 30, 2023 -1.19 Mn
Jun 30, 2023 -2.00 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 -5.31 Mn
Mar 31, 2023 -5.31 Mn
Dec 31, 2022 -5.45 Mn
Dec 31, 2022 -5.45 Mn
Sep 30, 2022 -6.40 Mn
Sep 30, 2022 -6.40 Mn
Jun 30, 2022 -381,000.00
Jun 30, 2022 -381,000.00
Mar 31, 2022 -3.38 Mn
Mar 31, 2022 -3.38 Mn
Dec 31, 2021 -20.22 Mn
Dec 31, 2021 -20.22 Mn